BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14617122)

  • 1. Methadone dosage for prevention of opioid withdrawal in children.
    Siddappa R; Fletcher JE; Heard AM; Kielma D; Cimino M; Heard CM
    Paediatr Anaesth; 2003 Nov; 13(9):805-10. PubMed ID: 14617122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU.
    Lugo RA; MacLaren R; Cash J; Pribble CG; Vernon DD
    Pharmacotherapy; 2001 Dec; 21(12):1566-73. PubMed ID: 11765307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically ill children transitioning from fentanyl -infusions to methadone.
    Hintze TD; Miller JL; Neely SB; Lim SY; Gupta N; Johnson PN
    J Opioid Manag; 2023; 19(1):43-56. PubMed ID: 36683300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of methadone tapering schedules in pediatric intensive care unit patients exposed to prolonged sedative infusions.
    Bowens CD; Thompson JA; Thompson MT; Breitzka RL; Thompson DG; Sheeran PW
    Pediatr Crit Care Med; 2011 Sep; 12(5):504-11. PubMed ID: 21076361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone conversion in infants and children: Retrospective cohort study of 199 pediatric inpatients.
    Fife A; Postier A; Flood A; Friedrichsdorf SJ
    J Opioid Manag; 2016; 12(2):123-30. PubMed ID: 27194197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats.
    Townsend EA; Blough BE; Epstein DH; Negus SS; Shaham Y; Banks ML
    Neuropsychopharmacology; 2022 Nov; 47(12):2132-2139. PubMed ID: 35906489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal syndrome in the pediatric intensive care unit. Incidence and risk factors.
    Fernández-Carrión F; Gaboli M; González-Celador R; Gómez de Quero-Masía P; Fernández-de Miguel S; Murga-Herrera V; Serrano-Ayestarán O; Sánchez-Granados JM; Payo-Pérez R
    Med Intensiva; 2013 Mar; 37(2):67-74. PubMed ID: 22608303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of methadone to facilitate opioid weaning in pediatric critical care patients: a systematic review of the literature and meta-analysis.
    Dervan LA; Yaghmai B; Watson RS; Wolf FM
    Paediatr Anaesth; 2017 Mar; 27(3):228-239. PubMed ID: 28109052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradycardia during methadone therapy in an infant.
    Wheeler AD; Tobias JD
    Pediatr Crit Care Med; 2006 Jan; 7(1):83-5. PubMed ID: 16395081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients.
    Meyer MM; Berens RJ
    Pediatr Crit Care Med; 2001 Oct; 2(4):329-33. PubMed ID: 12793936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children.
    Tobias JD
    Crit Care Med; 1999 Oct; 27(10):2262-5. PubMed ID: 10548218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU.
    Tobias JD
    J Opioid Manag; 2006; 2(4):201-5. PubMed ID: 17319480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children.
    Johnson PN; Harrison D; Allen C
    J Opioid Manag; 2010; 6(2):117-24. PubMed ID: 20481176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid withdrawal in critically ill neonates.
    Dominguez KD; Lomako DM; Katz RW; Kelly HW
    Ann Pharmacother; 2003 Apr; 37(4):473-7. PubMed ID: 12659598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid and Benzodiazepine Withdrawal Syndrome in PICU Patients: Which Risk Factors Matter?
    da Silva PS; Reis ME; Fonseca TS; Fonseca MC
    J Addict Med; 2016; 10(2):110-6. PubMed ID: 26927302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of enteral methadone on the ability to wean off continuously infused opioids in critically ill, mechanically ventilated adults: a case-control study.
    Al-Qadheeb NS; Roberts RJ; Griffin R; Garpestad E; Ruthazer R; Devlin JW
    Ann Pharmacother; 2012 Sep; 46(9):1160-6. PubMed ID: 22872749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
    Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
    Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid withdrawal signs and symptoms in children: frequency and determinants.
    Fisher D; Grap MJ; Younger JB; Ameringer S; Elswick RK
    Heart Lung; 2013; 42(6):407-13. PubMed ID: 24008186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Sedation Weaning Protocol on Safety and Medication Use among Hospitalized Children Post Critical Illness.
    Solodiuk JC; Greco CD; O'Donnell KA; Morrill DR; Curley MAQ
    J Pediatr Nurs; 2019; 49():18-23. PubMed ID: 31470315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.